Advances in genetic manipulation are showing promise for mitigating glaucomatous damage and preserving sight.
Some prescription and OTC treatments our patients may be receiving can affect the disease—for better or worse.
Doing surgery on these patients requires a different approach than you might use for other glaucoma patients. Here's help.
Evidence suggests that these drugs cause a long-term IOP reduction in some patients. Here's the latest.
Patients are increasingly curious about this. A doctor/researcher provides an update.
A number of these procedures, including anti-VEGF injections, can trigger a rise in IOP. A retinal specialist offers advice.
Pharmacy-made drops can be an affordable and beneficial option for many of our patients.
Could this technology benefit many relatively healthy eyes, not just those with advanced glaucoma? Two experts weigh in on the issue.
A very low intraocular pressure can have negative consequences when performing cataract surgery. Here's help.
Recent studies offer insight regarding whether or not to perform laser peripheral iridotomy on these patients.